Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
about
Characterization of the oligomeric structure of the Ca(2+)-activated Cl- channel Ano1/TMEM16ATaking stock of gene therapy for cystic fibrosisUp-regulation of acid-gated Na(+) channels (ASICs) by cystic fibrosis transmembrane conductance regulator co-expression in Xenopus oocytesOntogeny of CLCN3 chloride channel gene expression in human pulmonary epitheliumPathophysiology of gene-targeted mouse models for cystic fibrosisCFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epitheliumOvercoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsStatus of gene therapy for cystic fibrosis lung diseaseEffective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors.Effect of host modification and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vectorCurrent status of gene therapy for cystic fibrosis pulmonary disease.CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivoTwo cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.Cystic fibrosis in adults. From researcher to practitioner.Correction of defective CFTR/ENaC function and tightness of cystic fibrosis airway epithelium by amniotic mesenchymal stromal (stem) cells.Effects of cystic fibrosis and congenital bilateral absence of the vas deferens-associated mutations on cystic fibrosis transmembrane conductance regulator-mediated regulation of separate channelsGene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency.Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteineNon-viral gene transfer therapy for cystic fibrosis.Cystic fibrosis and the relationship between mucin and chloride secretion by cultures of human airway gland mucous cells.Emerging drug treatments for cystic fibrosis.Cystic Fibrosis Gene Therapy in the UK and Elsewhere.Bimodal control of a Ca(2+)-activated Cl(-) channel by different Ca(2+) signals.Novel molecular approaches to cystic fibrosis gene therapy.Cystic fibrosis transmembrane conductance regulator-associated ATP release is controlled by a chloride sensorRegulation of murine airway surface liquid volume by CFTR and Ca2+-activated Cl- conductancesPolarized signaling via purinoceptors in normal and cystic fibrosis airway epithelia.Cystic fibrosis mouse models.Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials.Relationships among CFTR expression, HCO3- secretion, and host defense may inform gene- and cell-based cystic fibrosis therapiesGene therapy for the treatment of cystic fibrosis.Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosisIncorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo.Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.Stem cell therapy for cystic fibrosis: current status and future prospects.Current status and future directions of gene and cell therapy for cystic fibrosis.Metabolic alkalosis in adults with stable cystic fibrosis.Expert opinion in biological therapy: update on developments in lung gene transfer.Lentiviral vectors and cystic fibrosis gene therapy
P2860
Q24598620-B8D78AF1-EA6B-49D6-BCD7-B91E18F25A25Q24791317-DFF38011-2F74-4152-A6BB-361CB7CEDA7DQ28211828-9FBF963C-4002-4653-9271-ED3427090387Q28212863-9EEDC63E-FC6A-4B54-A196-34750F42C374Q28295602-C16718B4-1B7C-44E8-8A9B-8138F66FCF6CQ28941756-3584F741-8AB0-42C1-89BF-93F88DDD3971Q30650955-731C2A8D-0975-4225-8CCA-52D982C37D60Q33533855-3D800D8A-F225-42A5-8CED-A878BC94FBF5Q33770522-975F1CBB-19FF-469C-9A26-30C703133A34Q33785297-01988AB3-0127-4E74-A1A2-608DE435278EQ33975113-7A3ABF42-EEBE-440D-AE8E-3509EBBE05CFQ34016471-13395B5B-6BDE-4BF8-B0D9-F9499B61B5CDQ34080254-4D54C114-34AA-4A02-9CE5-1B61A612F103Q34183284-C50D641C-CA61-4661-BEC3-735D867621ACQ34311234-7C497A04-543A-47B7-9026-0EEE16DD8B04Q34390399-70D765D7-B720-4881-988E-FCF17B277C02Q34768922-3F546AA1-321C-44DE-8323-05AB27C26A1DQ35007154-6D13ACAB-EC3E-4F16-AFA1-23A93D62EE86Q35144032-8869DB92-65AE-412B-8E75-F83A657BE66FQ35325201-8D2F86BB-CB46-4AFC-9FFA-113354DECA7CQ35602683-CC77D9CB-95E3-41E0-81C9-7B033CAE463DQ35641704-3D9ED5D7-227A-4632-AC61-B6134A1671FAQ35834782-161925F0-3F66-4BC7-A921-67DE4A0D788AQ36012920-4C7C1954-DDE9-4863-9EBF-14E802A40A9EQ36288182-F6FAE86D-BA88-4286-B0B8-DD29C822C5DCQ36436450-7526DDCA-6905-487D-8D69-1645FFE626BEQ36442042-5AACC652-5FF9-4CA4-891D-66615E719D83Q36556391-B0E9389A-B964-47E7-AF9B-7415EB9BB6EDQ36891541-856755AE-2C18-41C6-8DB3-42D87747801AQ36904905-3E85AC39-66A1-4562-8947-D8AFB468D6E7Q36925241-A205FFA9-0AF6-48A2-BAF2-2EB5B2F44D82Q37353301-5CC64206-C6F2-4496-8D87-250081CB236AQ37387177-BCC93E6D-55F4-476A-8290-3D52B7B195C8Q37462330-E50F883B-1E85-47D2-A9EA-29FB7A4029C5Q37526991-44BFA93F-C2B6-428D-B7F5-81175280684EQ37754873-395E1638-381C-4006-8DC6-7C65F8D2A354Q37858512-50C31532-D171-458E-B85F-69850FB45C30Q38035851-E8FDA4D0-C340-496F-A638-EC6C34E26264Q38071683-6CD11AAD-14D5-454D-81B8-44E9AF8F5E6CQ38614351-2774CD32-6511-4C4B-AF2E-B1E57C3D48B8
P2860
Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Normalization of raised sodium ...... rosis airway epithelial cells.
@ast
Normalization of raised sodium ...... rosis airway epithelial cells.
@en
type
label
Normalization of raised sodium ...... rosis airway epithelial cells.
@ast
Normalization of raised sodium ...... rosis airway epithelial cells.
@en
prefLabel
Normalization of raised sodium ...... rosis airway epithelial cells.
@ast
Normalization of raised sodium ...... rosis airway epithelial cells.
@en
P2093
P2860
P921
P356
P1476
Normalization of raised sodium ...... rosis airway epithelial cells.
@en
P2093
L G Johnson
R C Boucher
S E Boyles
P2860
P304
P356
10.1172/JCI117789
P407
P577
1995-03-01T00:00:00Z